Introducing A New Innovative, Incision-Free Treatment from Gynesonics.

MedStar Health is the first health system to provide Sonata, an incision-free, uterus-preserving, outpatient treatment option for women  with symptomatic Uterine Fibroids

Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that MedStar Health, a not-for-profit health system of 4,300 affiliated physicians and 10 hospitals, ambulatory care and urgent care centers, has introduced the Sonata® Procedure in the Maryland and Washington, D.C. area. The first case at MedStar Health was performed by Vadim Morozov, M.D., the Director of the American Academy of Gynecologic Laparoscopists (AAGL) Fellowship in Minimally Invasive Gynecologic Surgery at MedStar Washington Hospital Center.

Fibroids are benign growths in or around the uterus, with about 70 percent of white women and more than 80 percent of black women having uterine fibroids before the age of 50. Uterine fibroids may cause significant and debilitating symptoms, including heavy menstrual bleeding. Symptoms may worsen over time if fibroids are left untreated, which leads to more than two million women in the U.S. undergoing treatment for uterine fibroids each year.





Author: umnitso

Managing Editor at ProfoMedia, and Senior Partner at The CRT Partnership, a a leading specialist in brokering international alliances and partnerships; a published author in own right - as well as accredited media for major trade associations, including HIMSS, Vitalis, and others.

Leave a Reply